Athersys Inc. has seen its stock price hit over the last three months, falling from a nice base of $1.50 all summer to today's lows at $1. This has happened despite numerous positive trial data from its drugs, as well as an outperform in its sector, stem cells.
http://seekingalpha.com/article/1037951-athersys-should-gain-at-least-50?source=feed
http://seekingalpha.com/article/1037951-athersys-should-gain-at-least-50?source=feed
No comments:
Post a Comment